Ballew Neal

Ballew Neal, chief accounting officer at Omega Healthcare Investors (OHI), has filed 39 Form 4 transactions over the past year, but the pattern is overwhelmingly mechanical rather than discretionary. Across all filings, Neal has recorded zero open-market purchases and zero open-market sales. The $875 in total sell value consists entirely of code "D" transactions—shares sold back to the issuer—while the roughly $49,900 in acquired value stems from code "A" grants and code "M" option exercises, both of which are compensation-related and not indicative of a directional bet on the stock. The recent activity follows a rigid quarterly rhythm. On July 1, 2026, Neal received a $6,258 grant (code "A") and immediately sold $524.48 back to the company (code "D"), mirroring identical transactions on April 1, 2026 ($6,258 grant, $350.56 disposition) and January 1, 2026 ($6,208.97 grant, $532.08 withheld for taxes under code "F"). Each quarter also includes paired option exercises (code "M") valued at zero on the last day of the prior month—June 30, March 31, and December 31—suggesting routine vesting schedules. The only outlier is a January 13, 2026 grant with no corresponding sale, but it too falls under compensation. The data reveals no conviction trading. Neal’s Form 4 history is a textbook case of an executive accumulating shares through scheduled equity awards and immediately disposing of a small fraction to cover tax obligations or issuer buybacks. The absence of any code "P" or "S" transactions—the only codes that reflect open-market decisions—means Neal has not voluntarily added to or trimmed a position in OHI during the covered period. For investors monitoring insider sentiment, this filing stream offers no signal beyond the predictable mechanics of a compensation plan.